Bellehsen Mayer, Stoycheva Valentina, Cohen Barry H, Nidich Sanford
The Unified Behavioral Health Center for Military Veterans and their Families, Northwell Health, Bay Shore, NY, USA.
Center for Traumatic Stress Resilience and Recovery, Northwell Health Glen, Oaks, NY.
J Trauma Stress. 2022 Feb;35(1):22-31. doi: 10.1002/jts.22665. Epub 2021 Mar 18.
Preliminary studies have demonstrated the efficacy of Transcendental Meditation (TM) for treating posttraumatic stress disorder (PTSD). The present study extended previous research with a pilot trial of TM as a treatment for PTSD via a single-blinded, randomized controlled design. veterans with PTSD (N = 40) were assigned to a TM intervention or treatment-as-usual (TAU) control group. Participants in the TM group engaged in 16 sessions over 12 weeks, primarily in a 60-min group format. Change in PTSD symptoms, measured via the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) was the primary outcome. Secondary outcomes included self-reported PTSD symptoms, depression, anxiety, sleep difficulties, anger, and quality of life (QoL). Assessments were conducted at baseline and 3-month follow-up. Mean CAPS-5 score decreases were significantly larger for participants in the TM group (M = -11.28, 95% CI [-17.35, -5.20]), compared to the TAU group (M = -1.62, 95% CI [-6.77, 3.52]), p = .012, d = -0.84. At posttest, 50.0% of veterans in the TM group no longer met PTSD diagnostic criteria as compared to 10.0% in the TAU group, p = .007. Adjusted mean changes on self-report measures of PTSD symptoms, depression, anxiety, and sleep difficulties indicated significant reductions in the TM group compared to TAU, ds = .80-1.16. There were no significant group differences regarding anger or QoL. These findings demonstrate the efficacy of TM as a treatment for veterans with PTSD and for comorbid symptoms. Combined with other research, they suggest that TM may be a tolerable, non-trauma-focused PTSD treatment.
初步研究已证明超觉静坐（TM）对治疗创伤后应激障碍（PTSD）有效。本研究通过单盲随机对照设计，对TM作为PTSD治疗方法的初步试验扩展了先前的研究。40名患有PTSD的退伍军人被分配到TM干预组或常规治疗（TAU）对照组。TM组的参与者在12周内进行了16次课程，主要采用60分钟的小组形式。通过《精神疾病诊断与统计手册》第5版临床医生管理的PTSD量表（CAPS-5）测量的PTSD症状变化是主要结果。次要结果包括自我报告的PTSD症状、抑郁、焦虑、睡眠困难、愤怒和生活质量（QoL）。在基线和3个月随访时进行评估。与TAU组（M = -1.62，95%CI [-6.77, 3.52]）相比，TM组参与者的平均CAPS-5得分下降幅度显著更大（M = -11.28，95%CI [-17.35, -5.20]），p = .012，d = -0.84。在测试后，TM组中50.0%的退伍军人不再符合PTSD诊断标准，而TAU组为10.0%，p = .007。PTSD症状、抑郁、焦虑和睡眠困难的自我报告测量指标的调整后平均变化表明，与TAU组相比，TM组有显著降低，ds = .80 - 1.16。在愤怒或生活质量方面没有显著的组间差异。这些发现证明了TM作为PTSD退伍军人及其共病症状治疗方法的有效性。与其他研究相结合，它们表明TM可能是一种可耐受的、非创伤聚焦的PTSD治疗方法。
